Literature DB >> 16876764

Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.

Fredrik Ekström1, Yuan-Ping Pang, Malin Boman, Elisabet Artursson, Christine Akfur, Susanne Börjegren.   

Abstract

Inhibition of acetylcholinesterase (AChE) by organophosphorus compounds (OPs) such as pesticides and nerve agents causes acute toxicity or death of the intoxicated individual. The inhibited AChE may be reactivated by certain oximes as antidotes for clinical treatment of OP-intoxications. Crystal structures of the oximes HI-6, Ortho-7 and obidoxime in complex with Mus musculus acetylcholinesterase (mAChE) reveal different roles of the peripheral anionic site (PAS) in the binding of the oximes. A limited structural change of the side chains of Trp286 and Asp74 facilitates the intercalation of the 4-carboxylamide pyridinium ring of HI-6 between the side chains of Tyr124 and Trp286. The 2-carboxyimino pyridinium ring of HI-6 is accommodated at the entrance of the catalytic site with the oximate forming a hydrogen bond to the main-chain nitrogen atom of Phe295. In contrast to HI-6, the coordination of Ortho-7 and obidoxime within the PAS is facilitated by an extended structural change of Trp286 that allows one of the carboxyimino pyridinium rings to form a cation-pi interaction with the aromatic groups of Tyr72 and Trp286. The central chain of Ortho-7 and obidoxime is loosely coordinated in the active-site gorge, whereas the second carboxyimino pyridinium ring is accommodated in the vicinity of the phenol ring of Tyr337. The structural data clearly show analogous coordination of Ortho-7 and obidoxime within the active-site gorge of AChE. Different ability to reactivate AChE inhibited by tabun is shown in end-point reactivation experiments where HI-6, Ortho-7 and obidoxime showed an efficiency of 1, 45 and 38%, respectively. The low efficiency of HI-6 and the significantly higher efficiency of Ortho-7 and obidoxime may be explained by the differential binding of the oximes in the PAS and active-site gorge of AChE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876764     DOI: 10.1016/j.bcp.2006.05.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates.

Authors:  Francine S Katz; Stevan Pecic; Timothy H Tran; Ilya Trakht; Laura Schneider; Zhengxiang Zhu; Long Ton-That; Michal Luzac; Viktor Zlatanic; Shivani Damera; Joanne Macdonald; Donald W Landry; Liang Tong; Milan N Stojanovic
Journal:  Chembiochem       Date:  2015-09-09       Impact factor: 3.164

2.  Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.

Authors:  Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Troy Wymore; Donald K Blumenthal; Palmer Taylor; Zoran Radić; Andrey Kovalevsky
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

3.  Induced-fit or preexisting equilibrium dynamics? Lessons from protein crystallography and MD simulations on acetylcholinesterase and implications for structure-based drug design.

Authors:  Yechun Xu; Jacques Ph Colletier; Hualiang Jiang; Israel Silman; Joel L Sussman; Martin Weik
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

4.  Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics.

Authors:  Yechun Xu; Jacques-Philippe Colletier; Martin Weik; Hualiang Jiang; John Moult; Israel Silman; Joel L Sussman
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

5.  Synthesis and Molecular Properties of Nerve Agent Reactivator HLö-7 Dimethanesulfonate.

Authors:  Fu-Lian Hsu; Su Y Bae; Jack McGuire; Dana R Anderson; Stephanie M Bester; Jude J Height; Scott D Pegan; Andrew J Walz
Journal:  ACS Med Chem Lett       Date:  2019-03-28       Impact factor: 4.345

6.  Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.

Authors:  Shibaji Ghosh; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

7.  Differential binding of bispyridinium oxime drugs with acetylcholinesterase.

Authors:  Manoj K Kesharwani; Bishwajit Ganguly; Amit Das; Tusar Bandyopadhyay
Journal:  Acta Pharmacol Sin       Date:  2010-02-08       Impact factor: 6.150

8.  Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase.

Authors:  Lukas Gorecki; Oksana Gerlits; Xiaotian Kong; Xiaolin Cheng; Donald K Blumenthal; Palmer Taylor; Carlo Ballatore; Andrey Kovalevsky; Zoran Radić
Journal:  J Biol Chem       Date:  2020-02-04       Impact factor: 5.157

9.  Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes.

Authors:  Uttamkumar Samanta; Stephen D Kirby; Prabhavathi Srinivasan; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

10.  Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator.

Authors:  Kamil Kuca; Kamil Musilek; Martin Paar; Daniel Jun; Petr Stodulka; Martina Hrabinova; Jan Marek
Journal:  Molecules       Date:  2007-08-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.